Investment thesis
Nina Capital is a health technology investor that deploys pre-seed and seed capital into need-driven companies applying information technology to healthcare, explicitly excluding drugs and vaccines. Founded in 2019, it writes tickets of €200K to €1.5M and invests across Europe, the United States, Israel, Canada and Australia. It manages three funds and has backed 58 companies in 18 countries.
Past investments
| Company | Round | Date | Round size |
|---|---|---|---|
| Rivia Zurich, Switzerland | Series A | Mar 2026 | €13M |